Biopharma Q&A Interview; Dr. Steve N. Slilaty Ph.D., Chairman, CEO of Sunshine Biopharma (OTCQB: SBFM) Shares Insight into Recent Company Move and Updates Lead Cancer Compound Adva-27a

New York, NY, Point Roberts, WA - December 19, 2013 (Investorideas.com Biotech Newswire) Investorideas.com, a research and news portal covering leading sectors, issues an exclusive Q&A interview with Dr. Steve N. Slilaty Ph.D., Chairman and CEO of Sunshine Biopharma Inc. (OTCQB: SBFM). Sunshine is Biopharma a pharmaceutical company focused on the research, development and commercialization of drugs for the treatment of various forms of cancer.

Dr. Steve N. Slilaty shares insight to the recent news that it has re-domiciled in Canada for expansion through acquisitions and to gain access to various financing opportunities available to Canadian corporations, in addition to updating the current status of its lead cancer product Adva-27a.
Q: Investorideas.com
Dr. Slilaty can you explain to investors the significance of the recent move to Canada corporately and what direct benefits are realized?
A: Dr. Steve N. Slilaty Ph.D., Chairman, CEO
There are several advantages relating to the fiscal environment in Canada which are conducive to companies planning to expand through acquisitions. For example, there are provisions in the Canadian Tax Act which allow Canadian companies to acquire other Canadian companies in a share exchange transaction on a tax exempt basis. In addition, there are significant tax credits available to Canadian companies conducting R&D in Canada and Sunshine’s drug development program would benefit a great deal such tax provisions.
Q: Investorideas.com
For investors unfamiliar with your company, can you give a brief history of some of the data and testing on your lead compound Adva-27a and the basic principle of how it works?
A: Dr. Steve N. Slilaty Ph.D., Chairman, CEO
Adva-27a is Topoisomerase 2 inhibitor. Suppression of Topoisomerase 2 enzyme activity is a well-established anticancer target. Unlike all existing Topoisomerase 2 inhibitors, Adva-27a continues to work even when cells become multidrug resistant. This remarkable property is unique to Adva-27a! Our preclinical studies to date have shown that:

• Adva-27a is effective at killing different types of multidrug resistant cancer cells, including:
• Breast Cancer Cells (MCF-7/MDR)
• Small-Cell Lung Cancer Cells (H69AR)
• Uterine Cancer (MES-SA/Dx5)
• Pancreatic Cancer (Panc-1)
• Adva-27a is unaffected by P-Glycoprotein, the enzyme responsible for making cancer cells resistant to anti-tumor drugs
• Adva-27a has excellent clearance time (half-life = 54 minutes) as indicated by human microsomes stability studies and pharmacokinetics data in rats
• Adva-27a clearance is independent of Cytochrome P450, a mechanism that is less likely to produce toxic intermediates
• Adva-27a is an excellent inhibitor of Topoisomerase II with an IC50 of only 13.7 micromolar
• Adva-27a has shown excellent pharmacokinetics profile as indicated by studies done in rats
• Adva-27a does not inhibit tubulin assembly
• Adva-27a exhibits low toxicity levels as indicated by measurements using the non-cancerous cell line, HMEC

Q: Investorideas.com
With data on multiple cancers, is there one area the company will focus on specifically?
A: Dr. Steve N. Slilaty Ph.D., Chairman, CEO
Yes, we are initially focused on treating breast cancer patients whose disease has become multidrug resistant. These patients currently have no treatment options available to them as all existing anticancer drugs cease to work. We are anxious to make our Adva-27a available to them soon. To this end, we have signed an agreement with McGill University’s Jewish General Hospital here in Montreal ( Canada) to conduct Phase I clinical trials on such patients. This is the first step in our clinical development program of Adva-27a.
Q: Investorideas.com
For investors unfamiliar with the difference between getting approval in Canada vs. US FDA approval, can you explain the process in Canada, the timelines, cost and what is next for Sunshine Biopharma?
A: Dr. Steve N. Slilaty Ph.D., Chairman, CEO
The approval process in Canada is very similar to that of the United States. Health Canada has very similar guidelines to those established by the FDA in the U.S. In fact, our Phase I clinical trials protocols are compliant with the requirements on both sides of the boarder and we will be able to file our results both in Canada and the US pretty much simultaneously. In terms of timelines, like the U.S., Canada has a so-called “fast-track” process for which is available for drugs that treat terminally ill patients as is the case with Adva-27a. Next, we anticipate initiating the human trials following completion of our next round of financing.
About Adva-27a
Adva-27a is Sunshine Biopharma's lead anticancer compound, a small molecule that has recently been shown to be effective at killing multidrug resistant breast cancer cells, small-cell lung cancer cells, uterine sarcoma cells and pancreatic cancer cells (Published in ANTICANCER RESEARCH, Volume 32, Pages 4423-4432, October 2012). Adva-27a is currently in the IND-Enabling stage of development. The original U.S. patent covering Adva-27a was issued on August 7, 2012 under US patent number 8,236,935.
About Sunshine Biopharma Inc. (OTCQB: SBFM):
Sunshine Biopharma is a pharmaceutical company focused on the research, development and commercialization of drugs for the treatment of various forms of cancer. The Company's lead compound, Adva-27a targets aggressive forms of cancer www.sunshinebiopharma.com
Recent news: http://finance.yahoo.com/news/sunshine-biopharma-domicile-canada-expansion-130000999.html
About InvestorIdeas.com:
InvestorIdeas.com is a global news source for investors following leading business sectors including biotech, tech, mining, mobile, energy, water, defense and security, renewable energy, food and beverage stocks and Latin American stocks.
Follow Investorideas.com on Twitter http://twitter.com/#!/Investorideas
Follow Investorideas.com on Facebook http://www.facebook.com/Investorideas
Follow Investorideas.com News on Linkedin.com/today at http://www.linkedin.com/today/investorideas.com
Sign up for our free news alerts
http://www.investorideas.com/Resources/Newsletter.asp
Become an Investorideas.com Member and use our online stock directories to research stocks - waters stocks, renewable energy, tech, mobile, mining stocks and more… http://www.investorideas.com/membership/
Disclaimer/ Disclosure: The Investorideas.com newswire is a third party publisher of news and research as well as creates original content as a news source. Original content created by investorideas is protected by copyright laws other than syndication rights. Investorideas is a news source on Google news and Linkedintoday plus hundreds of syndication partners. Our site does not make recommendations for purchases or sale of stocks or products. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. All investment involves risk and possible loss of investment. This site is currently compensated by featured companies, news submissions, content marketing and online advertising. Contact each company directly for press release questions. Disclosure is posted on each release if required but otherwise the news was not compensated for and is published for the sole interest of our readers. Disclosure: SBFM compensates Investorideas for news publication and distribution (one hundred thousand 144 shares in lieu of cash for a six month period) more disclaimer info: http://www.investorideas.com/About/Disclaimer.asp
BC Residents and Investor Disclaimer : Effective September 15 2008 - all BC investors should review all OTC and Pink sheet listed companies for adherence in new disclosure filings and filing appropriate documents with Sedar. Read for more info: http://www.bcsc.bc.ca/release.aspx?id=6894. Global investors must adhere to regulations of each country.
800-665-0411 -   Source - www.Investorideas.com

Solar Stock XsunX (OTCQB: XSNX) to Deliver Several New Commercial Solar Systems

ALISO VIEJO, CA - December 19, 2013 (Investorideas.com renewable energy newswire) XsunX, Inc. (OTCQB: XSNX), a renewable energy technology, systems, and services company, today announced the successful sale of an additional 20kW commercial solar system in Southern California. This comes on the heels of 50kW of solar systems projects announced earlier this week.

"We are pleased with the sales results we announced this week, but we are even more pleased with the response to our media marketing campaign that was launched last week targeting major Southern California communities from Ventura to San Diego," stated XsunX CEO, Tom Djokovich.
Southern California represents one of the largest commercial PV system markets in the nation and a tremendous opportunity for the Company. Mr. Djokovich continued, "We are finding that business owners with large facilities and large electric bills are contacting us to see how XsunX can help them. We are just now starting to get our message out and the response has been very good. Our focus is on providing reliable services to these businesses."
The Company has specifically targeted the commercial and industrial PV installations market for several reasons. While the sales cycle can be more complex and lengthy, the projects offer XsunX the ability to generate system sales approaching 1 megawatt or more and potentially millions of dollars in contract value. In addition, commercial PV systems offer clients the largest cash benefits, and return on investment.
To help secure sales, the Company can now offer system financing to its customers. "Our goal was to make buying a commercial PV system as easy for our clients as buying a car," offered Mr. Djokovich. "We recently qualified to offer up to $1 million of project funding which completes our ability to offer the best project financial analysis, PV systems design and technologies, and zero down low interest financing."
About XsunX
XsunX focuses on providing solar energy solutions that provide the greatest bottom-line financial benefits. The Company's background and experience spans virtually all aspects of solar including technology assessment, design, and development. We have a deep passion for solar and have worked to pioneer new technologies and solar business solutions focused at making solar an affordable energy option. For more information, please visit the Company's website at www.xsunx.com.
Safe Harbor Statement
Matters discussed in this release contain forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. All statements other than statements of historical facts included in this press release are forward-looking statements. These statements relate to future events or to the Company's future financial performance, and involve known and unknown risks, uncertainties and other factors that may cause our actual results, levels of activity, performance or achievements to be materially different from any future results, levels of activity, performance or achievements expressed or implied by these forward-looking statements. Investors should not place any undue reliance on forward-looking statements since they involve known and unknown, uncertainties and other factors which are, in some cases, beyond the Company's control which could, and likely will, materially affect actual results, levels of activity, performance or achievements. Any forward-looking statement reflects the Company's current views with respect to future events and is subject to these and other risks, uncertainties and assumptions relating to operations, results of operations, growth strategy and liquidity. Such risks, uncertainties and other factors, which could impact the Company and the forward-looking statements contained herein, are included in the Company's filings with the Securities and Exchange Commission. The Company assumes no obligation to publicly update or revise these forward-looking statements for any reason, or to update the reasons actual results could differ materially from those anticipated in these forward-looking statements, even if new information becomes available in the future.
Contact:
Tom Djokovich
President and CEO
949-330-8060
info@xsunx.com
Disclaimer/ Disclosure: The Investorideas.com newswire is a third party publisher of news and research as well as creates original content as a news source. Original content created by investorideas is protected by copyright laws other than syndication rights. Investorideas is a news source on Google news and Linkedintoday plus hundreds of syndication partners. Our site does not make recommendations for purchases or sale of stocks or products. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. All investment involves risk and possible loss of investment. This site is currently compensated by featured companies, news submissions, content marketing and online advertising. Contact each company directly for press release questions. Disclosure is posted on each release if required but otherwise the news was not compensated for and is published for the sole interest of our readers. Disclosure: Investorideas has been compensated by XSNX for news distribution averaging 1500 per month. http://www.investorideas.com/About/Disclaimer.asp

Biometric Stock Alert: NXT-ID, Inc. (OTCQB: NXTD) Appoints Two Former MasterCard Executives to Its Newly Formed Advisory Board

SHELTON, CT - December 17, 2013 (Investorideas.com Newswire) NXT-ID (OTCQB: NXTD), a biometrics company focused on the growing m-commerce market, announces the appointment of two key advisory board members, Mr. Lawrence Flanagan and Mr. Ken Moy. The appointments from the card payment industry align with the company's roll-out and 2014 launch of The Wocket™, a next generation biometrically secure wallet.

"We are honored and excited to have two luminaries of the card payment world on our advisory board," said Gino Pereira, CEO of NXT-ID, Inc. "Their experience is invaluable to our future prospects and growth for The Wocket™. We look forward to growing our advisory board over the next few months with equally talented and experienced individuals."
Mr. Lawrence Flanagan is President and Founder of New Tech Haven since January 2013 and was formerly the Executive Dean at the University of New Haven College of Business. Flanagan is regarded as one of the most accomplished global marketing leaders in the country. Prior to his career in academia, he spent nearly three decades in corporate America as an executive at MasterCard Worldwide, the Procter & Gamble Company and L'Oreal USA.
As the global chief marketing officer at MasterCard, he managed a $1.5 billion budget, directed marketing strategies in more than 50 countries and helped launch the company's hugely successful "Priceless" advertising campaign. He also established strategic partnerships with Major League Baseball, the PGA Tour and Champions League soccer in Europe and was part of the executive team that spearheaded MasterCard's highly successful initial public offering in 2006. He earned six Gold Effie awards from the American Marketing Association, the most prestigious honor among marketing professionals, and was recognized as one of the "25 Most Influential People in Sports" in 2004 by SportBusiness International. In 2008, the NY AdClub named Flanagan "Person of the Year". In 2013, the University of New Haven awarded a Doctor of Business Administration honoris causa to Flanagan.
Flanagan, who is a former national co-chair of the CMO Collective, is active with Save the Children and previously served on the University of New Haven's Board of Governors. He is on the advisory boards of Visitdays.com and Fraud.net.
The second appointment, Mr. Ken Moy, was formerly senior vice president and Group Head of US Emerging Payments at MasterCard Worldwide.
Moy led the execution of the company's digital conversion strategy and managed all aspects of product development and a diverse set of existing products including online and offline payments, authentication solutions, spending controls and alerts services. He launched MasterPass, the firm's digital wallet solution and important pillar to overall strategy, achieving over 25,000 online merchants, and wallet distribution with over 20 financial institutions.
Moy has extensive experience in large-scale rollouts, partnerships, corporate development, strategic planning, business administration and product management, in the technology, commerce and financial services space. He led an exclusive agreement with Google, Citibank and First Data to launch Google Wallet, the first commercially available mobile payment solutions. He also led an exclusive agreement with Intel for access to embedded technology in Intel PCs to deliver enhanced security and user experience for electronic ecommerce.
Prior to his nearly 14 year career at MasterCard, Mr. Moy enjoyed a successful 10 year career at Citibank where he held a range of leadership roles in the firm's payment cards and wholesale banking businesses.
He was a Smart Card Alliance Board Member from 2004-2010 and is a frequent industry speaker and commentator.
Presently, Moy is Founder and President of Harvest Advisors LLC, a provider of strategy, business development and implementation advice to start-ups and technology solution providers in the developing commerce space.
NXT-ID, Inc. released the first images of The Wocket™ on its corporate website and product website late last week.
About The Wocket™
The Wocket™ is a next generation designed to replace all the cards in your wallet without draining your cell phone's battery; no smart phone required. The Wocket works anywhere credit cards are accepted and only works with your biometric stamp of approval. http://thewocket.com/
About NXT-ID Inc. - Mobile Security for a Mobile World
NXT-ID, Inc.'s (OTCQB: NXTD) innovative MobileBio™ solution mitigates consumer risks associated with mobile computing, m-commerce and smart OS-enabled devices. The company is focused on the growing m-commerce market, launching its innovative MobileBio™ suite of biometric solutions that secure consumers' mobile platforms. NXT-ID's wholly owned subsidiary, 3D-ID LLC, is engaged in biometric identification and has 22 licensed patents in the field of 3D facial recognition http://www.nxt-id.com/, http://3d-id.net/
Forward-Looking Statements for NXT-ID
This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Forward-looking statements reflect management's current expectations, as of the date of this press release, and involve certain risks and uncertainties. Forward-looking statements include statements herein with respect to the successful execution of the Company's business strategy. The Company's actual results could differ materially from those anticipated in these forward-looking statements as a result of various factors. Such risks and uncertainties include, among other things, our ability to establish and maintain the proprietary nature of our technology through the patent process, as well as our ability to possibly license from others patents and patent applications necessary to develop products; the availability of financing; the Company's ability to implement its long range business plan for various applications of its technology; the Company's ability to enter into agreements with any necessary marketing and/or distribution partners; the impact of competition, the obtaining and maintenance of any necessary regulatory clearances applicable to applications of the Company's technology; and management of growth and other risks and uncertainties that may be detailed from time to time in the Company's reports filed with the Securities and Exchange Commission.
Contact:
Investor Inquiries:
Kirin Smith
ProActive Capital Group
Direct: 646 863 6519
Disclaimer/ Disclosure: The Investorideas.com newswire is a third party publisher of news and research as well as creates original content as a news source. Original content created by investorideas is protected by copyright laws other than syndication rights. Investorideas is a news source on Google news and Linkedintoday plus hundreds of syndication partners. Our site does not make recommendations for purchases or sale of stocks or products. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. All investment involves risk and possible loss of investment. This site is currently compensated by featured companies, news submissions, content marketing and online advertising. Contact each company directly for press release questions. Disclosure is posted on each release if required but otherwise the news was not compensated for and is published for the sole interest of our readers. Disclosure: November 2013 :Investorideas is compensated by NXTD: five thousand per month for news publication and syndication and is long 144 shares from previous services
More info: http://www.investorideas.com/About/Disclaimer.asp
BC Residents and Investor Disclaimer : Effective September 15 2008 - all BC investors should review all OTC and Pink sheet listed companies for adherence in new disclosure filings and filing appropriate documents with Sedar. Read for more info: http://www.bcsc.bc.ca/release.aspx?id=6894. Global investors must adhere to regulations of each country.

Q&A Interview with CEO of Tekcapital; Open Innovation Network Enables Companies to Research and Acquire Game Changing Technology

New York, NY, Point Roberts, WA - December 13, 2013 (www.investorideas.com newswire) Investorideas.com issues an exclusive interview with Mr. Clifford M. Gross, Ph.D., Chief Executive Officer of Tekcapital. Dr. Gross shares insight into his company’s discovery search engine which identifies intellectual properties from 3300 plus universities and how they are enabling companies to gain market leadership over their competition with access to next- generation technology.

Q: Investorideas.com
Can you give a brief background on the history of the Company and how the database and network were developed?
A: Clifford M. Gross, Ph.D., Chief Executive Officer
Tekcapital was established by a team of Oxford University, Said business school graduates in June 2012. The problem that we sought to solve was how to help companies profit from new university-developed technologies and intellectual properties. As the pace of innovation has dramatically accelerated firms of all sizes have found it more difficult to remain competitive technologically by relying on in-house developed innovations and intellectual properties. Globally, universities produce roughly 100,000 new patents each year, yet 80% of these discoveries fail to be used commercially. We realized that this was in part due to market inefficiency. To address this we developed a market driven, turn-key solution to make it easy for companies to find, review and acquire the intellectual properties they need to improve and protect their products. The unique service we have developed incorporates global discovery search, objective scientific review of technologies and industry leading university to business transaction experience to help secure the deal.
The first step was to make the global university supplier network easily accessible. We achieved this by developing a new search engine that directly reaches into the technology commercialization offices of the world's leading research institutions. Currently, there are approximately 15,000 research institutions spread out over 160 countries. The top 3,300 of these institutions produce roughly 80% of the world's peer-reviewed, university-based, published scientific research. We believe, as do many of clients, that these institutions are the engine room for global technology development. So now, for the first time, we have made it easy for clients to find new developments available in any field of science, technology or medicine. Finding these technologies is just the first step. We provide actionable information for our clients, which mean technologies that fit our clients' needs and where the science has been vetted and verified by a subject matter expert. For this process we developed a science advisory council that could in real-time, objectively evaluate new intellectual properties for our clients. The final and most important step was to build a team that had significant technology acquisition experience. Our management team, collectively have closed more than 400 transactions from universities to businesses of all sizes.
Q: Investorideas.com
Can you give us some examples of the types of clients you assist and what sectors they are in?
A: Clifford M. Gross, Ph.D., Chief Executive Officer
Clients' usually engage us for one of two reasons. Either they are seeking to enhance their pipeline of intellectual properties to improve their innovation capabilities or they have identified a weakness in their intellectual property portfolio that they want to fill, to better protect their intellectual property. Clients range in size from early-stage firms to multi-nationals. Their sectors cover, new materials, medical devices, drugs, diagnostics, electronics, software, cloud computing, consumer products, energy and nutraceuticals.
Q: Investorideas.com
We are seeing technology advance faster than we could have imagined at this time in history. We have witnessed a lot of big companies disappear like dinosaurs because they didn't see what was coming next. Can you give us some insight as to what you are seeing first hand at the university level and how tapping into this rapid technology development can really impact the next phase of growth for companies?
A: Clifford M. Gross, Ph.D., Chief Executive Officer
Like individuals, companies have life spans. What's interesting is unlike individuals, the life-span of companies is becoming shorter as a result of the quickening pace of innovation. With the development and wide spread use of social networks, smart phones and tablets the innovation pace is continuing to accelerate. It's pretty easy to miss not only the next big development but perhaps the next five big developments in your space; primarily because they are not occurring inside of your organization and are not under your control. The net effect is technological obsolescence or market irrelevance. In our opinion, no amount of capital or historic brand luster can neutralize these corporate risks without the right strategy. We have re-imagined R&D primarily an external function, augmented by in-house development and marketing. For many companies this is a difficult concept to embrace as it requires the ability to relinquish the illusion of control over the technology development trajectory and tolerate the ambiguity of external innovation based on the fact that the majority of the world's finest minds reside outside of your organization. Once a firm understands and accept this concept, addressing the need for continuous innovation becomes a lot more manageable.
Q: Investorideas.com
For companies interested in your services can you give a brief explanation of how the relationship with Tekcapital, the university and the client works?
A: Clifford M. Gross, Ph.D., Chief Executive Officer
It's very straight forward. We are engaged under a retained relationship by our clients and we receive success fees upon closing transactions. For the universities of the world we are a no-cost channel partner that results in increased review and acquisition of their intellectual properties.
Q: Investorideas.com
Your Company has attracted an impressive executive management team: can you tell our readers the common vision that brought the team together?
A: Clifford M. Gross, Ph.D., Chief Executive Officer
We believe a company will never be better than the team that drives it forwards. As a team we are passionate about creating marketplace value from university intellectual property for our clients and seeing new innovations enter the market that can improve the quality of life.
About Tekcapital, Ltd. - The World's Largest University Network for Open Innovation
Tekcapital helps clients profit from new, university-developed intellectual properties. With our proprietary discovery search engine, linked to 3,300+ universities in 160 countries, coupled with expert scientific review, we provide a turn-key service to make it easy for clients to find and acquire the IP they need to create a competitive advantage. www.tekcapital.com
About InvestorIdeas.com:
InvestorIdeas.com is a global news source for investors following leading business sectors including biotech, tech, mining, mobile, energy, water, defense and security, renewable energy and Latin American stocks.
Follow Investorideas.com on Twitter   http://twitter.com/#!/Investorideas
Follow Investorideas.com on Facebook   http://www.facebook.com/Investorideas
Follow Investorideas.com News on Linkedin.com/today at http://www.linkedin.com/today/investorideas.com
Sign up for our free news alerts
http://www.investorideas.com/Resources/Newsletter.asp
Become an Investorideas.com Member http://www.investorideas.com/membership/
Disclaimer/ Disclosure: The Investorideas.com newswire is a third party publisher of news and research as well as creates original content as a news source. Original content created by investorideas is protected by copyright laws other than syndication rights. Investorideas is a news source on Google news and Linkedintoday plus hundreds of syndication partners. Our site does not make recommendations for purchases or sale of stocks or products. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. All investment involves risk and possible loss of investment. This site is currently compensated by featured companies, news submissions, content marketing and online advertising. Contact each company directly for press release questions. Disclosure is posted on each release if required but otherwise the news was not compensated for and is published for the sole interest of our readers. Disclosure: Tekcapital, a private company, has engaged Investorideas.com for public relations services.
More disclaimer info: http://www.investorideas.com/About/Disclaimer.asp
Global investors must adhere to regulations of each country.
800-665-0411 -   Source - www.Investorideas.com

Exosomes; Nano-Scale Bubbles Creating Waves in Diagnostics and Therapeutics

New York, NY, Point Roberts, WA - December 17, 2013 (Investorideas.com newswire) Investorideas.com, an investor news and research portal issues an exclusive sector snapshot on the rapidly growing exosome market and opportunities with key insight from Enal Razvi, Ph.D, Biotechnology Analyst and Managing Director of SelectBio U.S.

For investors unfamiliar with exosomes, they are cell-derived vesicles that are present in most biological fluids including blood and urine, as well as other body fluids. Because the fluids are easily accessible, they can be used as markers for disease progression. Exosomes are described as tiny, nano-scale bubbles that are released from cells capable of intercellular communication.
"Only five years ago the principals of communicating within the body were hormones, immunology or neurology and now we have found another way of communicating and sending genetic signals between cells,” Life Technologies Corp (LIFE).
So why is something so small creating such a huge buzz? Two key significant areas of growth in the sector are diagnostics and therapeutics for diseases such as cancer.
According to a report earlier this year from Select Biosciences, "Exosome research is growing exponentially as researchers from several disparate disciplines are exploring the role of exosomes in inter-cellular communication, immunological responses, stem cell behavior, cancer cell communication, etc. Indeed, the potential of exosomes and other classes of microvesicles as a means of molecular cargo transport is being intensively studied. "
Enal Razvi, Ph.D, Biotechnology Analyst and Managing Director of SelectBio U.S, one of a few experts covering the space, shared insight with Investorideas.com in a recent conversation.
When we asked Enal to discuss what publicly traded companies are in this new sector for investors, he said there are only a few to watch including Life Technologies Corp (LIFE) (currently being acquired by Thermo Fisher Scientific), Eli Lilly (LLY) (due to their partnership with Exosome Diagnostics) and Aethlon Medical (AEMD).
He went on to say, "Investors need to be aware of changes exosomes allow, making companion diagnostics a reality. Exosomes can create a paradigm shift for companion diagnostics based on circulating biomarkers.
"Five years from now, or sooner, exosomes will become a key diagnostic tool for cancers. If we don’t know the origin of tumors; biomarkers can narrow down the source.
Why investors should pay attention to the space is because exosomes can significantly reduce the cost and increase the compliance, primarily for cancer, and make biopsies for personal medicine longitudinal sense. It becomes a very invasive process for a patient to get ongoing biopsies, so this new method of using exosomes for diagnostics is very exciting for patients.
Currently the research market for exosomes is about $50 million but this does not account for the opportunities in the diagnostics space which will drive market growth and value creation.”
Aethlon Medical (OTCBB: AEMD) is one of the only companies that may be able to participate in both diagnostics and therapeutics in the exosome space. The company recently announced the launch of Exosome Sciences (ESI) as a subsidiary that is advancing exosome-based strategies to diagnose and monitor the progression of cancer, infectious disease and other life-threatening conditions. Aethlon also attracted two of the best-known thought leaders in the exosome industry to play key roles in the new company.
"We are well positioned to benefit from the exosome revolution,” stated Aethlon Medical Chairman and CEO, Jim Joyce. "We are advancing patented first-in-class therapeutic technology to eliminate the presence of tumor-secreted exosomes that trigger the death of immune cells necessary for combating cancer.  On the diagnostic front, our Exosome Sciences research team pioneered the field of exosome biology and is actively advancing a pipeline of next generation diagnostic tools".
In September of this year, Exosome Diagnostics announced that it entered into a collaboration agreement with Eli Lilly & Co. (NYSE:LLY). "Exosome Diagnostics technology may provide a unique opportunity to gain insight into the biology of complex conditions such as cancer and immune disorders”, stated Andrew Schade, Senior Medical Director, Diagnostic and Experimental Pathology at Eli Lilly. He further stated that "Exosome technology enables biofluid molecular sampling and the ability to monitor disease progression in real time. As Lilly explores new ways to pursue patient tailoring, we'll continue to work with partners to expand our capabilities."
Another company in the space, stem cell therapy development company ReNeuron (LON: RENE)
reported in early December, "We have highlighted a number of key developments in the period, notably the successful and earlier-than-planned development of a second-generation cryopreserved CTX drug product for our stroke and critical limb ischaemia programmes, our planned world-class cell manufacturing facility in South Wales, the granting of Orphan Drug Designation for our retinitis pigmentosa programme and the accelerated development of our CTX cell-based exosomes therapeutic platform”.
Life Technologies Corp (LIFE) has created a mini documentary series entitled 'Exosomes-The Next Small Thing’. "Exosomes are a very powerful way, a new way of how cells communicate long distance… They are powerful mediators that carry all the signaling and machinery necessary to change the behavior of the neighboring cells". http://www.lifetechnologies.com/ca/en/home/life-science/cell-analysis/exosomes/exosomes-documentary-episode-1.html
PDF for Exosomes Market Snapshot: Enal Razvi, Ph.D.
http://www.genengnews.com/media/pdf/GEN-Biomarket-Trends-Report-Exosomes%20Market-Landscape-2013.pdf
Bio for Enal Razvi, Ph.D- Biotechnology Analyst and Managing Director of SelectBio U.S
Enal Razvi, Ph.D., conducted his doctoral work on viral immunology and subsequent to receiving his Ph.D. went on to the Rockefeller University in New York to serve as Aaron Diamond Post-doctoral fellow under Professor Ralph Steinman [Nobel Prize Winner in 2011 for his discovery of dendritic cells in the early-70s with Zanvil Cohn]. Subsequently, Dr. Razvi completed his research fellowship at Harvard Medical School. For the last two decades Dr. Razvi has worked with small and large companies and consulted for more than 100 clients worldwide. He currently serves as Biotechnology Analyst and Managing Director of SelectBio U.S. He can be reached at enal@selectbio.us
About Aethlon Medical, Inc. (AEMD)
Aethlon Medical creates innovative medical devices to address life-threatening diseases. The Aethlon ADAPT™ (Adaptive Dialysis-like Affinity Platform Technology) establishes the basis for a new class of therapeutics that target the rapid elimination of disease enabling particles from the circulatory system of treated patients. The lead Aethlon ADAPT™ product is the Hemopurifier®, a device that addresses a broad-spectrum of viral pathogens as well as tumor-secreted exosomes that suppress the immune system of cancer patients. Aethlon is also operating under two government contracts with the Defense Advanced Research Projects Agency (DARPA) related the development of a medical device to reduce the incidence of sepsis. Exosome Sciences, Inc. is a majority owned Aethlon subsidiary that is advancing exosome-based strategies to diagnose and monitor cancer and infectious disease progression. Additional information can be found at www.AethlonMedical.com
News source: http://www.hispanicbusiness.com/2013/12/4/reports_from_dalian_medical_university_advance.htm
About InvestorIdeas.com:
InvestorIdeas.com is a global news source for investors following leading business sectors including biotech, tech, mining, mobile, energy, water, defense renewable energy and Latin American stocks.
Follow Investorideas.com on Twitter   http://twitter.com/#!/Investorideas
Follow Investorideas.com on Facebook   http://www.facebook.com/Investorideas
Follow Investorideas.com News on Linkedin.com/today at http://www.linkedin.com/today/investorideas.com
Sign up for news alerts:
http://www.investorideas.com/Resources/Newsletter.asp
Become an Investorideas.com Member http://www.investorideas.com/membership/
Disclaimer/ Disclosure: The Investorideas.com newswire is a third party publisher of news and research as well as creates original content as a news source. Original content created by investorideas is protected by copyright laws other than syndication rights. Investorideas is a news source on Google news and Linkedintoday plus hundreds of syndication partners. Our site does not make recommendations for purchases or sale of stocks or products. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. All investment involves risk and possible loss of investment. This site is currently compensated by featured companies, news submissions, content marketing and online advertising. Contact each company directly for press release questions. Disclosure is posted on each release if required but otherwise the news was not compensated for and is published for the sole interest of our readers. More disclaimer info: http://www.investorideas.com/About/Disclaimer.asp Disclosure: AEMD compensates Investorideas three thousand per month for news and content publication and distribution
BC Residents and Investor Disclaimer : Effective September 15 2008 - all BC investors should review all OTC and Pink sheet listed companies for adherence in new disclosure filings and filing appropriate documents with Sedar. Read for more info: http://www.bcsc.bc.ca/release.aspx?id=6894. Global investors must adhere to regulations of each country.
800-665-0411 -   Source - www.Investorideas.com

Solar Stock XsunX (OTCQB: XSNX) Announces Sales and Building Momentum Into 2014

ALISO VIEJO, CA - December 16, 2013 (Investorideas.com renewable energy newswire) XsunX, Inc. (OTCQB: XSNX), a renewable energy technology, systems, and services company, today announced adding 50kW in signed projects to its growing PV system development and installation services pipeline. The Company is focused on signing more solar contracts before year end.

"We are very excited about the rapid progress we have been making, and announcing 50kW in new projects just adds to our momentum," stated XsunX CEO, Tom Djokovich.
The Company has been working to develop solar projects for a diverse set of clients ranging from professional service companies, to ranch land, to large scale industrial reclamation. The Company has been working directly with new business clients to document the financial benefits available from solar for their businesses.
To help expand and accelerate the growth of the Company's PV system development and installation services business, XsunX has launched a media marketing campaign which targets major Southern California communities ranging from Ventura to the Inland Empire, LA, Orange County and portions of San Diego county. This market represents one of the largest commercial PV system markets in the country and thousands of potential commercial PV system clients for XsunX.
"The message and the reality is that solar has become far more than just a way to cut utility costs. A commercial PV system can provide clients with a 100% cash value return on their investment in as little as three years, and well in excess of a 1000% return on every dollar invested over the life of the system," concluded Mr. Djokovich.
About XsunX
XsunX focuses on providing solar energy solutions that provide the greatest bottom-line financial benefits. The Company's background and experience spans virtually all aspects of solar including technology assessment, design, and development. We have a deep passion for solar and have worked to pioneer new technologies and solar business solutions focused at making solar an affordable energy option. For more information, please visit the Company's website at www.xsunx.com.
Safe Harbor Statement
Matters discussed in this release contain forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. All statements other than statements of historical facts included in this press release are forward-looking statements. These statements relate to future events or to the Company's future financial performance, and involve known and unknown risks, uncertainties and other factors that may cause our actual results, levels of activity, performance or achievements to be materially different from any future results, levels of activity, performance or achievements expressed or implied by these forward-looking statements. Investors should not place any undue reliance on forward-looking statements since they involve known and unknown, uncertainties and other factors which are, in some cases, beyond the Company's control which could, and likely will, materially affect actual results, levels of activity, performance or achievements. Any forward-looking statement reflects the Company's current views with respect to future events and is subject to these and other risks, uncertainties and assumptions relating to operations, results of operations, growth strategy and liquidity. Such risks, uncertainties and other factors, which could impact the Company and the forward-looking statements contained herein, are included in the Company's filings with the Securities and Exchange Commission. The Company assumes no obligation to publicly update or revise these forward-looking statements for any reason, or to update the reasons actual results could differ materially from those anticipated in these forward-looking statements, even if new information becomes available in the future.
Contact:
Tom Djokovich
President and CEO
949-330-8060
info@xsunx.com
Disclaimer/ Disclosure: The Investorideas.com newswire is a third party publisher of news and research as well as creates original content as a news source. Original content created by investorideas is protected by copyright laws other than syndication rights. Investorideas is a news source on Google news and Linkedintoday plus hundreds of syndication partners. Our site does not make recommendations for purchases or sale of stocks or products. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. All investment involves risk and possible loss of investment. This site is currently compensated by featured companies, news submissions, content marketing and online advertising. Contact each company directly for press release questions. Disclosure is posted on each release if required but otherwise the news was not compensated for and is published for the sole interest of our readers. Disclosure: Investorideas has been compensated by XSNX for news distribution averaging 1500 per month. http://www.investorideas.com/About/Disclaimer.asp

Social Media Stock Alert: UMeWorld (OTCQB:UMEWF) Announces Recent Business Developments

HONG KONG - December 16, 2013 (Investorideas.com newswire) UMeWorld Limited (OTCQB: UMEWF) an emerging digital media company based in China, today announces its recent business developments as of December 16, 2013 and the outlook for the 1st quarter of 2014.

Press Releases Issued During the Period:

• Dec 3, 2013 - UMeWorld to Monetize its UMeLook Video Platform.
• Nov 26, 2013 - UMeWorld Releases UMFun™ Final Version, Praised by China State Media.
• Nov 8, 2013 - UMeWorld’s Video Platform Surpasses 7.2 Million Unique Visitors.
• Oct 14, 2013 - UMeWorld Launches Revamped Brand Channels on UMeLook.com.
• Oct 1, 2013 - UMeWorld Launches UMFun™.
• Sep 18, 2013 - UMeWorld Provides Corporate Update.

Recent Corporate Development During the Period:

• UMeWorld presents at SeeThruEquity Microcap Investor Conference in New York City.
• UMeWorld initiates two online Investor Relation programs.
• UMeWorld completes internal corporate development review and held discussions with two investment banks for Investment Banking and Advisory services.
• UMeWorld identifies an acquisition target and engages in negotiations.

Upcoming Development in the 1st Quarter of 2014:

• UMeLook to introduce Basic and Gold paid membership program to its Brand Channel.
• UMeLook to release an App optimized for Android tablets and Smartphones.
• UMFun to open an online store, where registered users will be able to use their U Coins (a virtual currency earned in UMeFun.com) to purchase gifts or services.
• UMFun to introduce an off-line Affiliate Program in which registered users will be rewarded by U Coins and Tools for introducing other users to UMFun.

About UMeWorld
UMeWorld's mission is to facilitate the interaction between people -- "You" and "Me," through its digital platform. Currently, UMeWorld operates UMeLook (www.umelook.com), an online video platform focused on bringing foreign video content to China. UMeLook is deployed through a sophisticated CDN (Content Delivery Network) with broad coverage throughout mainland China, Hong Kong & Taiwan. UMeLook plans to be a source of foreign video content for the Chinese viewer across any Internet-enabled device in China. UMeWorld intends to focus its future operations on digital media and the digital education market.
Forward Looking Statement
This release may contain projections and other forward-looking statements that involve risks and uncertainties. Forward-looking statements are projections reflecting management's judgment and assumptions based on currently available information and involve a number of risks and uncertainties that could cause actual results to differ materially from those suggested by the forward-looking statements. Future performance cannot be assured. Readers are referred to the documents filed by UMeWorld with the Securities and Exchange Commission (SEC), specifically the most recent reports which identify important risk factors that could cause actual results to differ from those contained in the forward-looking statements.
For more information, please contact:
UMeWorld Limited
Michael Lee, 852-2824-8716
Investor Relations
info@UMeWorld.com
Published at Investorideas.com – Big Ideas for Global Investors
Sign up for the free investor news and stock alerts at Investorideas.com
http://www.investorideas.com/Resources/Newsletter.asp
Disclaimer/ Disclosure : The Investorideas.com is a third party publisher of news and research Our sites do not make recommendations, but offer information portals to research news, articles, stock lists and recent research. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. This site is currently compensated by featured companies, news submissions and online advertising. Disclosure: UMEWF compensates Investorideas.com for news publication and syndication : one thousand per month
BC Residents and Investor Disclaimer: Effective September 15 2008 - all BC investors should review all OTC and Pink sheet listed companies for adherence in new disclosure filings and filing appropriate documents with Sedar. Read for more info: http://www.bcsc.bc.ca/release.aspx?id=6894

Ninth Annual "Livingston Nanotechnology Conference" December 11-13 in Midtown Manhattan ; New York 's largest and longest running gathering of investors, entrepreneurs and innovators interested in disruptive technologies

New York, New York - December 11, 2013 (www.investorideas.com newswire) Livingston Securities announces the 9th annual "Livingston Nanotechnology Conference" is being held from December 11-13 in Midtown Manhattan. This is New York 's largest and longest running gathering of investors, entrepreneurs and innovators interested in disruptive technologies.

Some highlights of this year's conference include:

A discussion with Harvard University 's leading developer of 4D printing technologies (3D printing with materials that can change their properties over time) A presentation from the X-Prize winner (Nokia sensing X-challenge) that has developed a working tri-corder (like in Star Trek) - a wireless, mobile, cheap, non-invasive diagnostic for a variety of diseases A panel on the "internet of things" Startup and early stage companies that are leading the race to commercialize technologies developed in space a trip to the Brookhaven National Labs to visit the Center for Functional Nanomaterials, the new DOE Center for Excellence for Advanced Energy Technologies, and the Relativistic Heavy Ion Collider Researchers from Microsoft, Harvard University and IBM discussing "quantum computing" A discussion on the JOBS Act, the Return of the Small IPO, and changes in the way that innovation is being financed on Wall Street and much, much more... Scott Livingston, Chief Executive Officer of Livingston Securities, said "We were founded in 2008 with three goals in mind: Finance the Nanotechnology Revolution (in all industries), change the way that innovation is financed on Wall Street, and connect you with your local innovation economy. 2013 has been a great year of change for innovators, entrepreneurs and those who finance them. We are excited to cap off this year with our best client and investor conference yet. You can learn more about Livingston Securities by visiting www.livingstonsecurities.com To learn more about our investor conference series and be added to our distribution list for future invitations please contact: Media@livingstonsecurities.com Jonathan Mason Tim Serignese Jordan Calabrese Jason Goldstein Disclaimer/ Disclosure:The Investorideas.com newswire is a third party publisher of news and research as well as creates original content as a news source. Original content created by investorideas is protected by copyright laws other than syndication rights. Investorideas is a news source on Google news and Linkedintoday plus hundreds of syndication partners. Our site does not make recommendations for purchases or sale of stocks or products. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. All investment involves risk and possible loss of investment. This site is currently compensated by featured companies, news submissions, content marketing and online advertising. Contact each company directly for press release questions. Disclosure is posted on each release if required but otherwise the news was not compensated for and is published for the sole interest of our readers. More disclaimer info: http://www.investorideas.com/About/Disclaimer.asp BC Residents and Investor Disclaimer : Effective September 15 2008 - all BC investors should review all OTC and Pink sheet listed companies for adherence in new disclosure filings and filing appropriate documents with Sedar. Read for more info: http://www.bcsc.bc.ca/release.aspx?id=6894. Global investors must adhere to regulations of each country.

Biometric Stock Alert: NXT-ID, Inc. (OTCQB: NXTD) Upcoming Release of Wocket(TM) Taps Into Ramping Demand for Digital Wallets and Currencies

BOSTON, MA - December 11, 2013 (Investorideas.com Newswire) SoundView Technology Group: New research note points to recent industry developments as important drivers to adoption of the upcoming NXT-ID (OTCQB: NXTD) Wocket.

Over 7 million consumers have watched a marketing video for a new digital wallet with a very limited feature set. Consumer interest in this product area is high and accelerating.
The commercial development of new digital currencies like Bitcoin has continued despite extreme price volatility. Industry leaders from companies like PayPal have acknowledged the value and viability of the new currency. At the same time mainstream venture capital firms like Andreesen Horowitz have stepped up their efforts to find "major bets" to make in this new market.
These industry developments increase our confidence and enthusiasm for the NXT-ID (NXTD) Wocket™ both as a digital wallet and a potential secure storage option for Bitcoins. As we outline in our note, the Wocket has a much more robust design in terms of security and usability.
We see the following as key advantages for the NXT-ID Wocket:
Security: Using a secure chip the Wocket can store 100s of cards and digital records. Authentication is multi-factor and includes biometrics. Cards go into the Wocket directly without involving unsecure intermediate steps.
Usability: The Wocket includes an ultra-lower power touchscreen display in addition to the dynamic magnetic stripe as both a UI and QR-code mechanism. A combination of power management, in-wallet charging and standard battery means that consumers won't have to fear a "dead wallet."
Flexibility: Rather than being tied to a phone or platform the Wocket can be paired with any device either locally or in the cloud when secure protocols are available. This dynamic pairing is a key feature of the NXT-ID approach and is a powerful and highly differentiated aspect of their technology.
NXT-ID is an early stage technology company going after a large market. Based on initial traction and a conservative intrinsic valuation (IV) model show a fair value of $11/share we see the company continuing to benefit from intensive investor attention to this space.
Our full report is available for download here: http://s3.amazonaws.com/Published_Research/NXT-ID_NXTD_NOTE_DEC_2013.pdf
About SoundView Technology Group
We are an independent advisory and research firm specializing in emerging technologies as they reach commercialization. Our proprietary research and modeling work provides valuable information for company management teams and investors in these emerging opportunities. We regularly publish our findings across a variety of channels including all the major retail and institutional information outlets. SoundView is based in Boston, Massachusetts with locations in New York and Connecticut.
Disclosures
SoundView analysts do not receive compensation for their research opinions, any specific views or conclusions. They are tasked to provide fact-based research with sound analysis. SoundView does not provide investment advice or make "buy/sell/hold" recommendations. Nor do we provide investment banking or brokerage services. We act as a publisher of our own research work and are responsible for all content which is correct to the best of our abilities but by no means should it be relied upon without further validation and confirmation. SoundView provides paid advisory services NXT-ID on their business plans, technology description and investor positioning
Contact:
Kris Tuttle
Director of Research
SoundView Technology Group
617-828-6462
Disclaimer/ Disclosure: The Investorideas.com newswire is a third party publisher of news and research as well as creates original content as a news source. Original content created by investorideas is protected by copyright laws other than syndication rights. Investorideas is a news source on Google news and Linkedintoday plus hundreds of syndication partners. Our site does not make recommendations for purchases or sale of stocks or products. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. All investment involves risk and possible loss of investment. This site is currently compensated by featured companies, news submissions, content marketing and online advertising. Contact each company directly for press release questions. Disclosure is posted on each release if required but otherwise the news was not compensated for and is published for the sole interest of our readers. Disclosure: November 2013 :Investorideas is compensated by NXTD: five thousand per month for news publication and syndication and is long 144 shares from previous services
More info: http://www.investorideas.com/About/Disclaimer.asp
BC Residents and Investor Disclaimer : Effective September 15 2008 - all BC investors should review all OTC and Pink sheet listed companies for adherence in new disclosure filings and filing appropriate documents with Sedar. Read for more info: http://www.bcsc.bc.ca/release.aspx?id=6894. Global investors must adhere to regulations of each country.